Table: Kringle Pharma - Q1 parent results

Kringle Pharma

07/02/2025 06:40

Feb 7 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Dec 31, 2024        Dec 31, 2023       Sep 30, 2025  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            18 mln              18 mln            272 mln     
                 (-2.8 pct)          (+7.6 pct)        (+239.8 pct)  
  Operating     loss 212 mln        loss 168 mln        loss 1.38    
  Recurring     loss 212 mln        loss 169 mln        loss 1.38    
  Net           loss 212 mln        loss 169 mln        loss 1.38    
  EPS          loss 31.23 yen      loss 29.53 yen    loss 202.70 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T